OCTOBER 2022LIFE SCIENCES REVIEW6Genomic sequencing has changed the way diseases are diagnosed and treated, as highlighted by the analysis of the human genome. Scientific endeavours in both the private and public sectors are enthusiastically embracing functional genomics techniques. These techniques are relatively new but have rapidly evolved and expanded into an exciting set of technologies, attracting massive research investment worldwide. Currently, the genomics market is envisaged to reach USD 8.26 billion, growing at a CAGR of 9.6 percent. The European genomics market is also expected to account for the second largest share of the global genomics market during the forecast period. A favourable reimbursement policy and increased investment in genomics centres are credited for driving market growth. Further advancements in biotechnology, such as next-generation sequencing, have made it possible to harvest data, develop analytics platforms, and create databases of rare genetic disorders.This edition of Life Sciences Review Europe features the list of the top ten Genomics Solutions Providers in Europe that underlines the importance and key developments occurring in the industry. DNA Sequence is a biotechnological firm that deploys Embed DNA technology in critical business operations. Similarly, The Arctic Therapeutics Company is an innovative drug discovery and development firm that provides precision-based drug development and diagnostic testing. The edition also features thought leadership insights from various expert CXOs and CIOs. Narayan Rao, Vice President of Biopharma, Asia Pacific Middle-East Africa, Avantor; Nick Thompson, Senior Director, Chemical Research and Development, Pfizer Inc, and Sebastian Horn, Vice President, Head of Global Patient Safety and Pharmacovigilance, Teva Pharmaceuticals, share their opinions on how genomics can lead humanity towards a better future by addressing the issues for the society, people, and planet. We hope the valuable insights from industry thought leaders and various organizations featured in this edition will guide you towards making better decisions for your organization.Let us know your thoughts.EDITORIALA Clear Line of Sight into DNA SequencingCopyright © 2022 ValleyMedia, Inc. All rights reserved. Reproduction in whole or part of any text, photography or illustrations without written permission from the publisher is prohibited. The publisher assumes no responsibility for unsolicited manuscripts, photographs or illustrations. Views and opinions expressed in this publication are not necessarily those of the magazine and accordingly, no liability is assumed by the publisher thereof.Email:sales@lifesciencesreview.comeditor@lifesciencesreview.commarketing@lifesciencesreview.com October - 13 - 2022, Vol 03, Issue - 23 (ISSN 2831-8331) Published by ValleyMedia, Inc.To subscribe to Life Sciences ReviewVisit www.lifesciencesreview.com Editorial StaffAaron PierceCarolynn Walters Paul BarberShirley FaithRussell Thomas Andrew KingsleyVisualizersMichael WayneDisclaimer: *Some of the Insights are based on our interviews with CIOs and CXOsJeremy WilliamsManaging Editoreditor@lifesciencesreview.comManaging EditorJeremy WilliamsKevin Scott
< Page 5 | Page 7 >